Qiagen NV | QIA - 现金及等价物

金融业

USD

USD 5.89B

现金及等价物

USD 646.29M

USD 196.45M

USD 1.66B

USD 581.45M

USD 1.65B

股息收益率

USD 0.9

USD 141.4M

USD 207.66M

USD 6.18K

EPS每股收益

USD 0.54

股本和储备

USD 3.36B

USD 340.39M

债务利息支出

USD 10.02M

USD 10.56M

USD 1.63B

USD 8.25B

USD 103.4M

USD 393.64M

USD 141.4M

普通股股本

USD 206.5M

16.72

USD 157.91M

USD 463.12M

销售和管理费用

USD 142.33M

USD 309.61M

贸易债权人

USD 79.08M

应收帐款人

USD 398.35M

	现金及等价物	更改		日
Akebia Therapeutics	USD 155.55M		7.1M	2026-06
Alaunos Therapeutics	USD 354K		1.03M	2026-03
argenx SE	USD 4.3B		808.71M	2026-03
Avita Medical	AUD 10.24M		1.98M	2025-12
Dianthus Therapeutics	USD 110.55M		517.12M	2026-06
Ionis Pharmaceuticals	USD 350.06M		1.57B	2026-06
IQVIA Holdings	USD 1.91B		38M	2026-06
Moderna	USD 1.72B		185M	2026-06
Organon & Co	USD 1.13B		16M	2026-06
Qiagen NV	USD 646.29M		192.72M	2026-03
Revvity	USD 1.02B		162.62M	2026-06
Tectonic Therapeutic	USD 236.89M		16.9M	2026-03
Viatris	USD 886.5M		917.7M	2026-06
Xeris Pharmaceuticals	USD 121.75M		10M	2026-06